NKTR stock forecast
Our latest prediction for Nektar Therapeutics's stock price was made on the Aug. 16, 2019 when the stock price was at 18.10$.
In the short term (2weeks), NKTR's stock price should outperform the market by 0.85%. During that period the price should oscillate between -6.73% and +15.18%.
In the medium term (3months), NKTR's stock price should outperform the market by 2.18%. During that period the price should oscillate between -14.59% and +40.88%.Get email alerts
About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.
At the moment the company generates 121M USD in revenues.
On its last earning announcement, the company reported a loss of -2.48$ per share.
The book value per share is 10.79$
Three months stock forecastAug. 16, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|